申请人:Connolly J. Peter
公开号:US20070225309A1
公开(公告)日:2007-09-27
The present invention is directed to substituted thiatriazaacenaphthylene-6-carbonitrile compounds of formula (I):
and forms thereof, their synthesis and use for treating, preventing or ameliorating a chronic or acute protein kinase mediated disease, disorder or condition.
本发明涉及公式(I)的取代噻三氮杂蒽-6-碳腈化合物及其形式,它们的合成和用于治疗、预防或改善慢性或急性蛋白激酶介导的疾病、紊乱或状况的用途。